Regional Fluorodeoxyglucose Metabolism and Instrumental Activities of Daily Living across the Alzheimer's Disease Spectrum

Journal of Alzheimer's Disease

Volumn 42, Issue 1, 2014, Pages 291-300

  Roy, Kamolika ^a,b   Pepin, Lesley C ^b   Philiossaint, Marlie ^b   Lorius, Natacha ^a,b   Becker, J Alex ^b   Locascio, Joseph J ^b   Rentz, Dorene M ^a,b   Sperling, Reisa A ^a,b   Johnson, Keith A ^a,b   Marshall, Gad A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

18fluorodeoxyglucose positron emission tomography; Alzheimer's disease; instrumental activities of daily living; mild cognitive impairment

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; BRAIN; BRAIN MAPPING; DISEASE COURSE; FACTUAL DATABASE; FOLLOW UP; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; SCINTISCANNING; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SURVEYS AND QUESTIONNAIRES;

EID: 84911447001     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131796     Document Type: Article

References (35)

1. Sperling RA, Jack CR, Jr., Aisen PS (2011) Testing the right target and right drug at the right stage. Sci Transl Med 3, 111cm133.
2. Alzheimer's Association (2012) Alzheimer's disease facts and figures. Alzheimers Dement 8, 131-168.
3. Luck T, Luppa M, Angermeyer MC, Villringer A, Konig HH, Riedel-Heller SG (2011) Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: Results of the Leipzig Longitudinal Study of the Aged. Psychol Med 41, 1087-1097.
4. Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA (2011) Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 7, 300-308.
5. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP(2002) Functional deficits in patients with mild cognitive impairment: Prediction of AD. Neurology 58, 758-764.
6. Marshall GA, Amariglio RE, Sperling RA, Rentz DM (2012) Activities of daily living: Where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag 2, 483-491.
7. Pfeffer RI, Kurosaki TT, Harrah CH, Jr., Chance JM, Filos S (1982) Measurement of functional activities in older adults in the community. J Gerontol 37, 323-329.
8. Morris JC (2012) Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch Neurol 69, 700-708.
9. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
10. Salmon E, Lespagnard S, Marique P, Peeters F, Herholz K, Perani D, Holthoff V, Kalbe E, Anchisi D, Adam S, Collette F, Garraux G (2005) Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol 252, 283-290.
11. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ (2012) The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement 8(1 Suppl), S1-68.
12. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7, 486-488.
13. Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention. The Haworth Press, New York, pp. 165-173.
14. Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K, Arahata Y, Kato T, Gjedde A (2010) Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: Probably even at early disease stages. Brain Struct Funct 214, 303-317.
15. Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, Peters J, Bartenstein P, Lieb K, Schreckenberger M (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44, 43-50.
16. Frazier JA, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, Herbert MR, Bent EK, Koneru VK, Dieterich ME, Hodge SM, Rauch SL, Grant PE, Cohen BM, Seidman LJ, Caviness VS, Biederman J (2005) Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry 162, 1256-1265.
17. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968-980.
18. Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone SV, Tsuang MT, Seidman LJ (2006) Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res 83, 155-171.
19. Goldstein JM, Seidman LJ, Makris N, Ahern T, O'Brien LM, Caviness VS, Jr., Kennedy DN, Faraone SV, Tsuang MT(2007) Hypothalamic abnormalities in schizophrenia: Sex effects and genetic vulnerability. Biol Psychiatry 61, 935-945.
20. Finner H (1993) On a monotonicity problem in step-down multiple test procedures. J Am Stat Assoc 88, 920-923.
21. Šidák Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62, 626-633.
22. Schroeter ML, Stein T, Maslowski N, Neumann J (2009) Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47, 1196-1206.
23. Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A (2008) Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 39, 619-633.
24. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25, 7709-7717.
25. La Joie R, Perrotin A, Barre L, Hommet C, Mezenge F, Ibazizene M, Camus V, Abbas A, Landeau B, Guilloteau D, de La Sayette V, Eustache F, Desgranges B, Chetelat G (2012) Region-specific hierarchy between atrophy, hypometabolism, and beta-amyloid (Abeta) load in Alzheimer's disease dementia. J Neurosci 32, 16265-16273.
26. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease:APET follow-up study. Eur J Nucl Med Mol Imaging 30, 1104-1113.
27. Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mezenge F, de la Sayette V, Viader F, Baron JC, Eustache F, ChetelatG(2009) Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 132(Pt 8), 2058-2067.
28. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL (2003) Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 11, 214-221.
29. Nadkarni NK, Levy-Cooperman N, Black SE (2012) Functional correlates of instrumental activities of daily living in mild Alzheimer's disease. Neurobiol Aging 33, 53-60.
30. de Gois Vasconcelos L, Jackowski AP, Oliveira MO, Flor YM, Bueno OF, Brucki SM(2011)Voxel-based morphometry findings in Alzheimer's disease: Neuropsychiatric symptoms and disability correlations - preliminary results. Clinics (Sao Paulo) 66, 1045-1050.
31. Vidoni ED, Honea RA, Burns JM (2010) Neural correlates of impaired functional independence in early Alzheimer's disease. J Alzheimers Dis 19, 517-527.
32. Royall DR, Palmer RF, Vidoni ED, Honea RA, Burns JM (2012) The default mode network and related right hemisphere structures may be the key substrates of dementia. J Alzheimers Dis 32, 467-478.
33. Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr. (2012) Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. Arch Neurol 69, 614-622.
34. Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D (2006) Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47, 1059-1066.
35. Locascio JJ, Jennings PJ, Moore CI, Corkin S (1997) Time series analysis in the time domain and resampling methods for studies of functional magnetic resonance brain imaging. Hum Brain Mapp 5, 168-193.